2 mg/day) did not result in AEs like pyrexia and rash, except for grade 1/2 liver dysfunction with elevated alkaline phosphatase/choline esterase, and AST/ALT; however, no dose adjustments or interruption of treatment were required. This evidence concerns the gene GPT and Decreased liver function.